Telomere shortening: a diagnostic tool and therapeutic target for cardiovascular disease?

被引：6
作者：
Muller, Majon [1 ]
Rabelink, Ton J. [2 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Internal Med, Sect Gerontol & Geriatr, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Internal Med, Sect Nephrol, Leiden, Netherlands
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷 / 46期
基金：
英国医学研究理事会;
关键词：
OXIDATIVE STRESS; LENGTH; AGE;
D O I：
10.1093/eurheartj/ehu252
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3245 / 3247
页数：3
相关论文
共 50 条
[21]   The potential of aldehyde dehydrogenase 2 as a therapeutic target in cardiovascular disease [J].
Muenzel, Thomas ;
Daiber, Andreas .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (03) :217-231
[22]   Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease [J].
Deshwal, Soni ;
Di Sante, Moises ;
Di Lisa, Fabio ;
Kaludercic, Nina .
CURRENT OPINION IN PHARMACOLOGY, 2017, 33 :64-69
[23]   CD38: A Potential Therapeutic Target in Cardiovascular Disease [J].
Zuo, Wanyun ;
Liu, Na ;
Zeng, Yunhong ;
Liu, Yaozhong ;
Li, Biao ;
Wu, Keke ;
Xiao, Yunbin ;
Liu, Qiming .
CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (04) :815-828
[24]   Indomethacin as a diagnostic and therapeutic tool in the management of progressive cervical shortening diagnosed by trans-vaginal sonography [J].
Kofinas, Alexander ;
Kofinas, Jason .
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2011, 24 (01) :79-85
[25]   No evidence of substantia nigra telomere shortening in Parkinson's disease [J].
Hudson, Gavin ;
Faini, David ;
Stutt, Andrea ;
Eccles, Martin ;
Robinson, Louise ;
Burn, David J. ;
Chinnery, Patrick F. .
NEUROBIOLOGY OF AGING, 2011, 32 (11) :2107.e3-2107.e5
[26]   Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort [J].
Nudelman, Kelly N. H. ;
Lin, Jue ;
Lane, Kathleen A. ;
Nho, Kwangsik ;
Kim, Sungeun ;
Faber, Kelley M. ;
Risacher, Shannon L. ;
Foroud, Tatiana M. ;
Gao, Sujuan ;
Davis, Justin W. ;
Weiner, Michael W. ;
Saykin, Andrew J. .
JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (01) :33-43
[27]   Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis [J].
Kim, Donghee ;
Li, Andrew A. ;
Ahmed, Aijaz .
LIVER INTERNATIONAL, 2018, 38 (10) :1839-1848
[28]   Rate of telomere shortening and cardiovascular damage: a longitudinal study in the 1946 British Birth Cohort [J].
Masi, Stefano ;
D'Aiuto, Francesco ;
martin-Ruiz, Carmen ;
Kahn, Tauseef ;
Wong, Andrew ;
Ghosh, Arjun K. ;
Whincup, Peter ;
Kuh, Diana ;
Hughes, Alan ;
von Zglinicki, Thomas ;
Hardy, Rebecca ;
Deanfield, John Eric .
EUROPEAN HEART JOURNAL, 2014, 35 (46) :3296-3303
[29]   Telomere shortening reduces Alzheimer's disease amyloid pathology in mice [J].
Rolyan, Harshvardhan ;
Scheffold, Annika ;
Heinrich, Annette ;
Begus-Nahrmann, Yvonne ;
Langkopf, Britta Heike ;
Hoelter, Sabine M. ;
Vogt-Weisenhorn, Daniela M. ;
Liss, Birgit ;
Wurst, Wolfgang ;
Lie, Dieter Chichung ;
Thal, Dietmar Rudolf ;
Biber, Knut ;
Rudolph, Karl Lenhard .
BRAIN, 2011, 134 :2044-2056
[30]   Immunosenescence and rheumatoid arthritis: Does telomere shortening predict impending disease? [J].
Costenbader, Karen H. ;
Prescott, Jennifer ;
Zee, Robert Y. ;
De Vivo, Immaculata .
AUTOIMMUNITY REVIEWS, 2011, 10 (09) :569-573
12345